Daqing Zhonglian Reliance Petroleum Technology Development Co., Ltd., established on 2013-12-09, Business scope includes oil drilling,exploration,Logging,Downhole operation technology development and technical services;Temporary plugging diversion to fracturing supercritical carbon dioxide fracturing stimulation,CO2 huff and puff to increase oil,low temperature catalytic oxidation,Nitrogen flooding to increase production,nano-fluid flooding,Enhanced Oil Field Recovery,Directional well,Ultra-short radius horizontal well drilling,Drilling speed,Drilling fluid field technology,Smart Completion Technology,Oil and water well plugging technology,Drainage and gas recovery,Water plugging and profile control,Insufflation huff and puff,find leaks,plugging,With pressure switch valve technology,microseismic monitoring,Production Profile Tracer Monitoring,Tracer interwell monitoring technology,Remaining Oil Saturation Monitoring,Capacity Profile Test,Production logging,Reservoir prediction,3D geological modeling,Numerical Simulation,The above technology development,consult,comminicate,transfer,Promotion service;Business Management Consulting Services;Testing service;data processing services;General storage;software development;Import and export,Technology Import and Export;Solid Waste Treatment;Petroleum machinery and equipment,Special equipment and accessories for oil drilling,water treatment equipment,Special equipment for environmental protection,Chemical Products,chemical additives,Coated quartz sand,Coated ceramsite(The above four items do not contain hazardous chemicals,Inflammable and explosive products and highly toxic)manufacturing and sales of(Except for projects prohibited and restricted by industrial policies);Civil UAV Sales;General cargo road transport.

Hypoxico Altitude Training is a company which is passionate about helping individuals exceed their expectations. If you are trying to climb Mt. Everest or run through Death Valley or anything in between, we will help you get it done.

Shiseido Co., Ltd. engages in the production and sale of cosmetics for men and women. It operates through the following segments: Japan, China, Asia Pacific, Americas, Europe, Travel Retail, Professional, and Others. The Japan, China, Asia Pacific, Americas, and Europe segments sell cosmetics, fragrance, and personal care products with core brands such as Shiseido, clé de peau BEAUTÉ, ELIXIR, MAQUILLAGE, AUPRES, urara, TSUBAKI, Za, and narciso rodriguez in each corresponding region. The Travel Retail segment retails Shiseido, clé de peau BEAUTÉ, bareMinerals, and NARS brands in airport duty-free shops excluding Japan. The Professional segment manages the sale of beauty products in Japan, China, and Asia. The Others segment includes headquarter functions, production, frontier science, and restaurant businesses. The company was founded by Arinobu Fukuhara on September 17, 1872 and is headquartered in Tokyo, Japan.

Baxter Healthcare SA engages in the development, production, and sale of healthcare systems and products. It also acquires and manages participations in pharmaceutical-chemical firms. The company was founded on December 7, 2000 and is headquartered in Glattpark, Switzerland.

KPC is a pharmaceutical company that engages in the manufacture of pharmaceuticals. Tablets, fluids, ointments, and injectables are among their offerings. Its goal is to improve people's lives by enabling them to achieve more, feel better, and live longer. They have technological machinery, skilled and motivated individuals, and management systems that can handle both quantity and quality of work. They are looking for new ways to improve their performance, raise their integrity to a level of excellence, implement their initiatives, and achieve their goals.

Nantong Huiqian New Material Technology Co., Ltd., established on 2015-07-21, The business scope includes nano new materials,biotechnology development,Technical Services;engineering plastics,Chemical Products(In addition to dangerous goods)research and development,Production,Sales;Zirconia,plastic products,carbon fiber,thickener,Daily chemical products and additives,cosmetic,Research and development and sales of flavors and fragrances.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. - The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. - The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. - The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.

Research Corporation Technologies, Inc. provides investment related services. It operates as technology development company that typically invests in new technology platforms in life sciences, healthcare technology, biomedical, preclinical and clinical-stage therapeutics, devices, drugs, and diagnostics, medical devices, and biotech tools for gene expression and protein production with medical devices. The company was founded in 1987 and is headquartered in Tucson, AZ.

Sandoz AG, a subsidiary of Novartis AG, is a company headquartered in Basel, Switzerland, that develops generic medicines and biosimilars.

Chengdu Zhia Technology Co., Ltd., established on 2017-03-21, The scope of business includes developing computer software and hardware and providing technical services;Network technology development,technical consulting;Information Technology Consulting;Technology intermediary service;Information system integration;Data processing and storage services;Industrial Product Design Services;Medical Research and Experimental Development;Agricultural Technology,Biotechnology,new material technology,Promotion of Energy Saving Technology;Educational Consulting(Does not include study abroad and intermediary services);Communication Engineering Design(Operating with a qualification certificate) ;Indoor and outdoor decoration engineering design,construction(Operating with a qualification certificate) ;design,make,acting,Place an ad(Does not contain balloon ads);sale furniture,household appliances,building materials(Free of Hazardous Chemicals),Industrial Automation Control Equipment. (Items subject to approval by law,Operations can only be carried out after approval by relevant departments).